Channels Management of HER2+ Breast Cancer with and without Brain Metastases in Saudi Arabia: Literature Insights and an Expert Survey of Current Practices
Astrocyte heterogeneity in brain metastases
First‐Line Alectinib Versus Ceritinib With or Without Brain Radiotherapy in ALK‐Positive Non‐Small Cell Lung Cancer with Brain Metastases: A Real‐World Multicenter Study from Vietnam
Brain metastases in non-small cell lung cancer: Prevalence, high-risk factors, and overall survival prognosis
HER2 Expression and Axillary Metastasis in Treatment-Naïve Early Breast Cancer
Artificial Intelligence-Driven Quantitative HER2 Scoring and Spatial Bystander Effect Modeling for ADC Response Stratification in HER2-Low Breast Cancer
The Impact of Androgen Receptor Expression on Neoadjuvant Therapy in HER2-Positive Breast Cancer
Abemaciclib in HR+, HER2− Breast Cancer: A Narrative Review of the Clinical Evidence
HER2 Heterogeneity in Breast Cancer: Biological Basis, Clinical Implications, and Therapeutic Strategies
Association Between Treatment Sequencing and Overall Survival in Stage IV NSCLC With Brain Metastases: A National Cancer Database Study
Nomogram integrating MRI radiomics and white matter hyperintensity grading for predicting overall survival in patients with non‐small cell lung cancer and brain metastases receiving whole‐brain radiotherapy
PET-MR Examination in Diagnosing Bone Metastases in Prostate Cancer
HER2 Overexpression in Invasive Breast Carcinoma in the Democratic Republic of Congo and its Association with Selected Clinicopathological Characteristics
Chemo‐Immunotherapy, a Combination Approach for the Treatment of HER2‐Positive Breast Cancer in a Mouse Model
Assessment of the Correlation Between Hypoalbuminemia and Adverse Effects of Oral Anticancer Medications in Adult Patients with Solid Tumors: A Single-Center Retrospective Cohort Study in Saudi Arabia
A Structured Classification of Pyrotinib-Containing Neoadjuvant Regimens for HER2-Positive Breast Cancer: Efficacy, Safety, and Regimen Selection
Histopathologic growth patterns as prognostic factor for survival in patients with colorectal liver metastases
Clinical Efficacy and Security Analysis of CDK4/6 Inhibitors Combined with ET in Patients with HR+HER2− Advanced Breast Cancer
Insights into a long life without cancer: The case of the bowhead whale
Research Progress of HER2 in Cervical Carcinoma
Intelligent nano‐platforms in breast cancer therapy: Current advances and future perspectives
Retrospective Analysis of HER2 Testing, Treatment Patterns, and Clinical Outcomes in Patients With Locally Advanced or Metastatic NSCLC With HER2 Mutations in France
Capecitabine versus Paclitaxel After CDK4/6 Inhibitor Progression in Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer: A Real-World Study
Daddy is dead: a physician reckons with her father’s mortality
Novel Insights into the Oncogenic Role and Clinical Significance of ORC6L in Breast Cancer
